HELEN OF TROY LIMITED (HELE) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-05-31..
- Stock-based compensation / revenue · 12 months: Value 1.27%; Formula and calculation Share-based compensation / revenue. Period ending 2026-05-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-05-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-05-31. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 1.27% | Share-based compensation / revenue. Period ending 2026-05-31. $23.03M ÷ $1.82B × 100 ≈ 1.27% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | Research and Development Expense |
| Revenue | 1.82B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 23.03M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -314.69M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-31 | (m) | $1.82B | $23.03M | $-314.69M | (m) | (m) | 1.27% | (m) | (m) |
| 2026-02-28 | $54.00M | $1.79B | $16.89M | $-782.08M | (m) | 3.02% | 0.95% | (m) | (m) |
| 2025-11-30 | (m) | $1.80B | $20.02M | $-729.11M | (m) | (m) | 1.11% | (m) | (m) |
| 2025-08-31 | (m) | $1.82B | $19.72M | $-645.62M | (m) | (m) | 1.08% | (m) | (m) |
| 2025-05-31 | (m) | $1.86B | $15.84M | $-295.05M | (m) | (m) | 0.85% | (m) | (m) |
| 2025-02-28 | $53.90M | $1.91B | $21.38M | $142.75M | (m) | 2.83% | 1.12% | (m) | (m) |
| 2024-11-30 | (m) | $1.91B | $24.82M | $206.91M | (m) | (m) | 1.30% | (m) | (m) |
| 2024-08-31 | (m) | $1.93B | $28.67M | $238.72M | (m) | (m) | 1.49% | (m) | (m) |
| 2024-05-31 | (m) | $1.95B | $30.41M | $250.71M | (m) | (m) | 1.56% | (m) | (m) |
| 2024-02-29 | $56.50M | $2.01B | $33.87M | $260.59M | $53.06M | 2.82% | 1.69% | 4.91× | Reported |
| 2023-11-30 | (m) | $2.00B | $19.80M | $248.13M | $54.63M | (m) | 0.99% | 4.54× | Reported |
| 2023-08-31 | (m) | $2.01B | $19.16M | $218.39M | $54.92M | (m) | 0.95% | 3.98× | Reported |
| 2023-05-31 | (m) | $2.04B | $19.43M | $218.49M | $50.43M | (m) | 0.95% | 4.33× | Reported |
| 2023-02-28 | $47.80M | $2.07B | $26.75M | $211.79M | $40.75M | 2.31% | 1.29% | 5.20× | Reported |
| 2022-11-30 | (m) | $2.17B | $38.32M | $208.46M | $30.02M | (m) | 1.77% | 6.94× | Reported |
| 2022-08-31 | (m) | $2.24B | $36.93M | $221.31M | $20.08M | (m) | 1.65% | 11.02× | Reported |
| 2022-05-31 | (m) | $2.19B | $37.22M | $241.65M | $14.22M | (m) | 1.70% | 16.99× | Reported |
| 2022-02-28 | $37.20M | $2.22B | $34.62M | $272.55M | $12.84M | 1.67% | 1.56% | 21.22× | Reported |
| 2021-11-30 | (m) | $2.15B | $34.11M | $246.69M | $12.56M | (m) | 1.59% | 19.65× | Reported |
| 2021-08-31 | (m) | $2.16B | $34.30M | $257.36M | $12.28M | (m) | 1.59% | 20.96× | Reported |
| 2021-05-31 | (m) | $2.22B | $31.15M | $289.34M | $11.77M | (m) | 1.40% | 24.59× | Reported |
| 2021-02-28 | $30.60M | $2.10B | $26.42M | $281.49M | $12.62M | 1.46% | 1.26% | 22.31× | Reported |
| 2020-11-30 | (m) | $2.03B | $24.84M | $254.22M | $12.98M | (m) | 1.22% | 19.58× | Reported |
| 2020-08-31 | (m) | $1.87B | $22.86M | $232.78M | $12.82M | (m) | 1.22% | 18.15× | Reported |
| 2020-05-31 | (m) | $1.75B | $24.62M | $188.02M | $13.24M | (m) | 1.41% | 14.20× | Reported |
| 2020-02-29 | $17.80M | $1.71B | $22.93M | $178.25M | $12.71M | 1.04% | 1.34% | 14.03× | Reported |
| 2019-11-30 | (m) | $1.65B | $23.77M | $225.09M | $12.60M | (m) | 1.44% | 17.87× | Reported |
| 2019-08-31 | (m) | $1.61B | $25.02M | $207.12M | $12.80M | (m) | 1.56% | 16.18× | Reported |
| 2019-05-31 | (m) | $1.59B | $23.33M | $203.26M | $12.34M | (m) | 1.47% | 16.47× | Reported |
| 2019-02-28 | $13.00M | $1.56B | $22.05M | $199.38M | $11.72M | 0.83% | 1.41% | 17.01× | Reported |
| 2018-11-30 | (m) | $1.58B | $21.46M | $186.72M | $11.38M | (m) | 1.36% | 16.41× | Reported |
| 2018-08-31 | (m) | (m) | $19.84M | $192.76M | $11.91M | (m) | (m) | 16.18× | Reported |
| 2018-05-31 | (m) | (m) | $18.24M | $181.81M | $12.91M | (m) | (m) | 14.08× | Reported |
| 2018-02-28 | $13.50M | $1.49B | $15.05M | $169.06M | $13.95M | 0.91% | 1.01% | 12.12× | Reported |
| 2017-11-30 | (m) | $1.57B | $14.97M | $41.87M | $15.04M | (m) | 0.95% | 2.78× | Reported |
| 2017-08-31 | (m) | $1.56B | $13.22M | $120.82M | $15.05M | (m) | 0.85% | 8.03× | Reported |
| 2017-05-31 | (m) | $1.55B | $13.07M | $138.20M | $15.04M | (m) | 0.84% | 9.19× | Reported |
| 2017-02-28 | $9.70M | $1.54B | $15.50M | $164.33M | $14.86M | 0.63% | 1.01% | 11.06× | Reported |
| 2016-11-30 | (m) | $1.55B | $14.00M | $139.71M | $14.10M | (m) | 0.91% | 9.91× | Reported |
| 2016-08-31 | (m) | $1.55B | $13.30M | $132.03M | $13.22M | (m) | 0.86% | 9.99× | Reported |
| 2016-05-31 | (m) | $1.55B | $12.04M | $126.97M | $11.86M | (m) | 0.78% | 10.71× | Reported |
| 2016-02-29 | $5.11M | $1.55B | $8.48M | $130.62M | $11.10M | 0.33% | 0.55% | 11.77× | Reported |
| 2015-11-30 | (m) | $1.54B | $7.58M | $163.56M | $11.57M | (m) | 0.49% | 14.14× | Reported |
| 2015-08-31 | (m) | $1.53B | $6.70M | $172.97M | $13.00M | (m) | 0.44% | 13.30× | Reported |
| 2015-05-31 | (m) | $1.48B | $6.74M | $165.14M | $14.50M | (m) | 0.46% | 11.39× | Reported |
| 2015-02-28 | (m) | $1.45B | $5.97M | $161.72M | $15.02M | (m) | 0.41% | 10.77× | Reported |
| 2014-11-30 | (m) | $1.38B | $27.02M | $129.50M | $14.13M | (m) | 1.96% | 9.16× | Reported |
| 2014-08-31 | (m) | $1.32B | $28.10M | $113.84M | $12.47M | (m) | 2.12% | 9.13× | Reported |
| 2014-05-31 | (m) | $1.32B | $29.60M | $119.60M | $10.67M | (m) | 2.23% | 11.21× | Reported |
| 2014-02-28 | (m) | $1.32B | $31.68M | $117.10M | $10.19M | (m) | 2.41% | 11.49× | Reported |
| 2013-11-30 | (m) | $1.33B | $10.70M | $140.11M | $11.32M | (m) | 0.80% | 12.38× | Reported |
| 2013-08-31 | (m) | $1.32B | $9.65M | $137.76M | $12.04M | (m) | 0.73% | 11.45× | Reported |
| 2013-05-31 | (m) | $1.29B | $7.69M | $138.25M | $12.97M | (m) | 0.59% | 10.66× | Reported |
| 2013-02-28 | (m) | $1.29B | $5.91M | $148.77M | $13.35M | (m) | 0.46% | 11.15× | Reported |
| 2012-11-30 | (m) | $1.26B | $5.11M | $145.60M | $12.94M | (m) | 0.41% | 11.25× | Reported |
| 2012-08-31 | (m) | $1.22B | $4.89M | $140.37M | $12.66M | (m) | 0.40% | 11.08× | Reported |
| 2012-05-31 | (m) | $1.21B | $4.06M | $139.88M | $12.80M | (m) | 0.34% | 10.93× | Reported |
| 2012-02-29 | (m) | $1.18B | $2.93M | $139.39M | $12.92M | (m) | 0.25% | 10.79× | Reported |
| 2011-11-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-08-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-05-31 | (m) | $888.36M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-02-28 | (m) | $777.04M | $2.02M | $111.74M | $9.69M | (m) | 0.26% | 11.53× | Reported |
| 2010-11-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-08-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-02-28 | (m) | $647.63M | $1.74M | $89.37M | $10.31M | (m) | 0.27% | 8.67× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aterian, Inc. (ATER) | United States | $0.012B | -0.86 |